Page 1120 - Veterinary Immunology, 10th Edition
P. 1120

endothelial cells can activate NK cells. Complement components
  VetBooks.ir  such as C5a and C3a may also activate antigen-presenting cells

               (APCs) within the graft.


               Adaptive Mechanisms


               Donor antigens are presented to the T cells of the recipient by
               APCs. The graft recipient may be sensitized by a direct pathway in
               which recipient T cells circulating through the graft encounter
               antigens presented by donor APCs. These donor APCs may also
               carry antigens to draining lymph nodes and the spleen.

               Alternatively, recipients may be sensitized when their own APCs
               enter the graft and encounter and process donor antigens (the
               indirect pathway). The direct pathway operates early in the

               rejection process but is replaced by the indirect pathway once
               donor APCs have been destroyed. In humans, the direct pathway is
               responsible for the vigorous immune response that occurs in acute
               rejection, whereas the indirect pathway is more important in
               chronic rejection. Although macrophages and dendritic cells are

               important APCs, donor B cells and tubular epithelial and
               endothelial cells can also process antigen, and they too can activate
               recipient T cells.

                  In laboratory rodents, MHC class II molecules are expressed on
               professional APCs. In these species, the intensity of graft rejection is
               related to the number of donor B cells, macrophages, and dendritic
               cells transplanted within the graft. Removal of these cells by careful
               flushing of the graft before surgery or by pretreatment of the donor

               with cytotoxic drugs greatly reduces the intensity of the rejection
               process. In other mammals in which MHC class II molecules are
               also expressed on vascular endothelial cells, these “passenger” cells

               are of less significance. Additionally, shed exosomes from the graft
               may enter the recipient and be captured by the host's APCs. These
               “cross-dressed” APCs may then be presented to recipient T cells.
                  The APCs that process donor MHC molecules migrate to the
               draining lymph node and activate T cells. The paracortical regions

               of lymph nodes draining a graft therefore contain dividing
               lymphocytes. The number of these cells is greatest about six days
               after grafting and declines rapidly once the graft has been rejected.

               In addition to these signs of an active T cell–mediated response,




                                                        1120
   1115   1116   1117   1118   1119   1120   1121   1122   1123   1124   1125